Publications by authors named "Lara Fontani"

Claim this Profile
E
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.
Cristina Chiriaco, Chiara Donini, Marco Cortese, Stefano Ughetto, Chiara Modica, Lara Fontani

J Exp Clin Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody.
Simona Cignetto, Chiara Modica, Cristina Chiriaco, Lara Fontani, Paola Milla

Mol Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib.
Valentina Sala, Simona Gallo, Stefano Gatti, Enzo Medico, Elisa Vigna, Lara Fontani

J Mol Cell Cardiol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30.
Elisa Vigna, Cristina Chiriaco, Simona Cignetto, Lara Fontani, Cristina Basilico

Mol Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy by gene transfer of a monovalent antibody fragment against the Met oncogenic receptor.
Elisa Vigna, Giovanni Pacchiana, Cristina Chiriaco, Simona Cignetto, Lara Fontani

J Mol Med (Berl)· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Active" cancer immunotherapy by anti-Met antibody gene transfer.
Elisa Vigna, Giovanni Pacchiana, Massimiliano Mazzone, Cristina Chiriaco, Lara Fontani

Cancer Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis